FDA granted accelerated approval to Enhertu for the treatment of adults with unresectable or metastatic HER2-positive breast cancer
This Viewpoint examines how modern precision oncology clinical trials, bolstered by decentralized trial tools, can enhance access to cancer treatments and reduce the burden of…
This cohort study examines the institution-level and patient-level factors associated with mismatch repair and microsatellite testing for individuals with colorectal cancer.
Nature Immunology – Here the authors provide a resource for ovarian cancer combining spatial transcriptomics, genomics, CRISPR Perturb-seq screens and in silico methods to focus…
Patients with brain tumours are motivated to participate in clinical trials involving repeat tissue sampling. Normalising the use of neoadjuvant and staged surgical trials necessitates…
This cross-sectional study examines the number of vacation days taken per year and the magnitude of physician work while on vacation and their association with…
This cross-sectional study examines the number of vacation days taken per year and the magnitude of physician work while on vacation and their association with…
Dr. Vivek Subbiah, drug development chief at the Sarah Cannon Research Institute, discusses medical advances to treat cancer and search for a cure. Dr. Erika…
Current evaluation of treatment response in solid tumors depends on dynamic changes in tumor diameters as measured by imaging. However, these changes can only be…
Driving Precision Oncology in India 🚀 We are proud to confirm Sewanti Limaye, MBBS, MD, MS, Director of Medical & Precision Oncology at Sir H.…
OncoInfluencers to Follow on Social Media: Dr. Vivek Subbiah / cancer, cancer therapeutics, cancer treatment, drug development, LinkedIn, MD Anderson Cancer
